The stock of OrthoPediatrics corp (KIDS) has seen a 11.13% increase in the past week, with a 21.90% gain in the past month, and a -2.13% decrease in the past quarter. The volatility ratio for the week is 8.12%, and the volatility levels for the past 30 days are at 5.55% for KIDS. The simple moving average for the past 20 days is 14.22% for KIDS’s stock, with a -4.48% simple moving average for the past 200 days.
Is It Worth Investing in OrthoPediatrics corp (NASDAQ: KIDS) Right Now?
Moreover, the 36-month beta value for KIDS is 1.14. Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 3 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for KIDS is 16.34M and currently, short sellers hold a 5.58% of that float. On January 20, 2025, KIDS’s average trading volume was 232.08K shares.
KIDS) stock’s latest price update
OrthoPediatrics corp (NASDAQ: KIDS)’s stock price has plunge by 2.37relation to previous closing price of 26.53. Nevertheless, the company has seen a 11.13% surge in its stock price over the last five trading sessions. globenewswire.com reported 2025-01-13 that Achieves all-time high full year 2024 Revenue of $205 million representing growth of 38% Year-Over-YearInitiates guidance for record adjusted EBITDA in 2025
Analysts’ Opinion of KIDS
Many brokerage firms have already submitted their reports for KIDS stocks, with Truist repeating the rating for KIDS by listing it as a “Hold.” The predicted price for KIDS in the upcoming period, according to Truist is $31 based on the research report published on January 25, 2024 of the previous year 2024.
Needham, on the other hand, stated in their research note that they expect to see KIDS reach a price target of $77, previously predicting the price at $70. The rating they have provided for KIDS stocks is “Buy” according to the report published on June 14th, 2021.
Needham gave a rating of “Buy” to KIDS, setting the target price at $46 in the report published on April 02nd of the previous year.
KIDS Trading at 11.51% from the 50-Day Moving Average
After a stumble in the market that brought KIDS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -24.53% of loss for the given period.
Volatility was left at 5.55%, however, over the last 30 days, the volatility rate increased by 8.12%, as shares surge +20.93% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.50% lower at present.
During the last 5 trading sessions, KIDS rose by +11.13%, which changed the moving average for the period of 200-days by +1.80% in comparison to the 20-day moving average, which settled at $23.78. In addition, OrthoPediatrics corp saw 17.17% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at KIDS starting from Gerritzen Daniel J, who sale 10,000 shares at the price of $29.30 back on Aug 21 ’24. After this action, Gerritzen Daniel J now owns 77,304 shares of OrthoPediatrics corp, valued at $293,000 using the latest closing price.
Bailey David R, the President and CEO of OrthoPediatrics corp, sale 3,213 shares at $27.59 during a trade that took place back on Mar 11 ’24, which means that Bailey David R is holding 139,384 shares at $88,647 based on the most recent closing price.
Stock Fundamentals for KIDS
Current profitability levels for the company are sitting at:
- -0.15 for the present operating margin
- 0.66 for the gross margin
The net margin for OrthoPediatrics corp stands at -0.15. The total capital return value is set at -0.06. Equity return is now at value -7.63, with -6.17 for asset returns.
Based on OrthoPediatrics corp (KIDS), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at -1.26. The debt to equity ratio resting at 0.07. The interest coverage ratio of the stock is -22.29.
Currently, EBITDA for the company is -8.38 million with net debt to EBITDA at 1.71. When we switch over and look at the enterprise to sales, we see a ratio of 3.33. The receivables turnover for the company is 4.43for trailing twelve months and the total asset turnover is 0.39. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.17.
Conclusion
To wrap up, the performance of OrthoPediatrics corp (KIDS) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
